An effective erythropoietin dose regimen protects against severe nerve injury-induced pathophysiological changes with improved neural gene expression and enhances functional recovery

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2020
Source ID
10.1016/j.intimp.2020.106330

Entities

People

  • Anagha A. Gurjar
  • John C Elfar
  • John P. Hegarty
  • M.a. Hassan Talukder
  • Prem Kumar Govindappa

Organizations

  • National Institutes of Health
  • Penn State College of Medicine
  • United States Department of Defense